Jens Meiler

Jens Meiler, Distinguished Research Professor of Chemistry, was named the principal investigator for the project, in cooperation with 14 investigators across eight institutions. The team will work together to use advanced technology, including computational modeling, AI-driven predictions and structural biology, to develop a groundbreaking vaccine against all alphaviruses that offers long-lasting protection. Read More

Using computer-aided drug design, Heidi Hamm, Craig Lindsley, and Jens Meiler and their labs generated a novel series of biologically active compounds that can serve as a basis for anti–blood clot preventative drugs. Read More

WATCH: Today’s fight against infectious diseases is being waged in the computer lab as much as the wet lab. Using artificial intelligence and machine learning, Vanderbilt researchers and students like School of Engineering undergraduate Karen Pu are expanding the power of computer modeling to identify mutating viruses—and potentially improve vaccines. Read More

Led by Vanderbilt University School of Medicine Basic Sciences professor Hassane Mchaourab, the Center for Applied Artificial Intelligence in Protein Dynamics will focus on the application of machine learning techniques to understand how proteins work. Read More

A Vanderbilt study suggests that clinicians should take a deeper dive into distinguishing EGFR mutations when prescribing targeted therapies for non-small-cell lung cancers. Read More

Provost and Vice Chancellor for Academic Affairs C. Cybele Raver joins six others at Vanderbilt as 2021 fellows of the American Association for the Advancement of Science, the world’s largest general scientific society. Read More

Cancer specialists at Vanderbilt University Medical Center, in partnership with biochemists and structural biologists across the Vanderbilt University campus, are taking “personalized” cancer therapy to a new level. Read More

All-remote collaboration results in free animal susceptibility tool to help prioritize research and closer examination of at-risk species. Read More

Vanderbilt’s newest endowed chair holders were celebrated for their path-breaking scholarship and research by family members, donors, colleagues and friends during a Feb. 25 ceremony. Read More

The computer-aided design and engineering of antibodies and vaccine candidates that can neutralize viral scourges like influenza and Ebola will be the topic of an Aug. 17 poster session presented by the Vanderbilt Center for Structural Biology and the Vanderbilt Vaccine Center. Read More

A Vanderbilt team and their international colleagues characterized for the first time a complex, little-understood cellular receptor type that, when activated, shuts off hunger. Read More

The Research IT Special Project Working Group will advance the efforts of the Provost’s Initiative to Enhance Research and Scholarship, or PIERS. Read More

Vanderbilt researchers have discovered a novel model of evolution for factors that control gene expression. Read More

High school students performing advanced research at Vanderbilt have the opportunity to share their findings with the scientific community through a journal of their own. Read More

It’s been known for some time that the immune system can produce antibodies capable of “neutralizing” HIV, and stopping the AIDS-causing virus dead in its tracks. Read More

Vanderbilt investigators are exploring the shape changes in a multidrug transporter to understand the mechanisms of antibacterial resistance. Read More

Associate Professor of Chemistry Jens Meiler has received a Friedrich Wilhelm Bessel Research Award from the Alexander von Humboldt Foundation in Bonn, Germany. Read More

Vanderbilt researchers have received a five-year, $9 million grant from the National Institutes of Health to design more effective flu vaccines and novel antibody therapies. Read More

With the help of a computer program called “Rosetta,” researchers at Vanderbilt University have “redesigned” an antibody that has increased potency and can neutralize more strains of the AIDS-causing human immunodeficiency virus (HIV) than can any known natural antibody. Read More

Vanderbilt University researchers have received a five-year, $9 million grant from the National Institutes of Health (NIH) to design more effective flu vaccines and novel antibody therapies. Read More